抗レトロウイルス治療の副作用
1HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, New South Wales, Australia. acarr@stvincents.com.au
Lancet (London, England)
|October 29, 2000
まとめ
抗レトロウイルス薬の毒性は,HIV患者にとって懸念が高まっている. このレビューでは,15種類の抗レトロウイルス薬の副作用の原因,症状,治療方法について詳しく述べています.
科学分野:
- 感染症 感染症は感染症です.
- 薬理学 薬理学とは
- クリニカル・メディシン 臨床医学
背景:
- HIV感染は,慢性疾患としてますます管理されています.
- 複数の抗レトロウイルス薬の長期使用は一般的です.
- HIV患者における機会性感染症は,著しく減少しています.
研究 の 目的:
- 抗レトロウイルス薬の毒性の病原性,臨床的特徴,および管理をレビューする.
- 15の認可された抗レトロウイルス薬に関連する主要な毒性をカバーするために.
- 薬剤特有の副作用と特殊な臨床環境での管理について議論する.
主な方法:
- 抗レトロウイルス薬の毒性の文献レビュー.
- 病原性および臨床的症状の分析.
- 現在の経営戦略をまとめました.
主要な成果:
- ミトコンドリアの毒性,過敏性,脂質消化症を含む主要な毒性を特定しました.
- 15種類の抗レトロウイルス薬の薬剤特有の詳細な副作用.
- 特定の患者集団における毒性の管理における課題を強調した.
結論:
- 抗レトロウイルス毒性は,HIVケアにおける注意深いモニタリングと管理を必要とします.
- 薬剤特異的な副作用を理解することは,効果的な治療に不可欠です.
- 抗レトロウイルス毒性の軽減に関するさらなる研究が必要である.
関連する概念動画
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


